Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00203
|
|||||
| Drug Name |
Aspirin
|
|||||
| Synonyms |
2-Acetoxybenzoic acid; 50-78-2; ACETYLSALICYLIC ACID; Acenterine; Aceticyl; Acetonyl; Acetophen; Acetosal; Acetosalin; Acetylin; Acetylsalicylate; Acidum acetylsalicylicum; Acylpyrin; Aspergum; Aspirdrops; Benaspir; Colfarit; Easprin; Ecolen; Ecotrin; Empirin; Endydol; Enterosarein; Globentyl; Micristin; O-Acetylsalicylic acid; Pharmacin; Polopiryna; Pravigard; Premaspin; Rheumintabletten; Rhodine; Salcetogen; Saletin; Salicylic acid acetate; Solprin acid; Temperal; o-Acetoxybenzoic acid; o-Carboxyphenyl acetate
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Pain [ICD11: MG30-MG7Z] | Approved | [1] | |||
| Therapeutic Class |
Analgesics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C9H8O4
|
|||||
| Canonical SMILES |
CC(=O)OC1=CC=CC=C1C(=O)O
|
|||||
| InChI |
InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)
|
|||||
| InChIKey |
BSYNRYMUTXBXSQ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-78-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 180.16 | Topological Polar Surface Area | 63.6 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10524572
, 11110749
, 11335730
, 11360969
, 11364139
, 11364685
, 11366701
, 11367247
, 11369263
, 11369809
, 11372248
, 11372850
, 11373537
, 11375409
, 11377425
, 11377972
, 11406615
, 11461941
, 11485574
, 11489715
, 11491110
, 11491914
, 11495059
, 15195166
, 17389202
, 17390036
, 17404602
, 24278218
, 24714725
, 24890623
, 24890723
, 24891140
, 26611613
, 26679412
, 26717767
, 3135921
, 4594
, 476106
, 5261264
, 602429
, 7847177
, 7885805
, 7978731
, 8143164
, 8149208
, 8151516
, 829042
, 832958
, 840714
, 87798
|
|||||
| ChEBI ID |
ChEBI:15365
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NPT1 | Transporter Info | Sodium-dependent phosphate transport protein 1 | Substrate | [2] | |
| OAT2 | Transporter Info | Organic anion transporter 2 | Substrate | [3] | ||
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [4] | ||
| SLC17A4 | Transporter Info | Probable small intestine urate exporter | Substrate | [5] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | NPT1 | Transporter Info | Km = 1900 microM | Oocytes-NPT1 | [2] | |
| References | ||||||
| 1 | Rosuvastatin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem. 2010 Aug 20;285(34):26107-13. | |||||
| 3 | Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett. 1998 Jun 12;429(2):179-82. | |||||
| 4 | Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22. | |||||
| 5 | A Na+-phosphate cotransporter homologue (SLC17A4 protein) is an intestinal organic anion exporter. Am J Physiol Cell Physiol. 2012 Jun 1;302(11):C1652-60. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.